The forecast for bladder malignant neoplasms mortality in Canada indicates a steady increase from 2.39 thousand deaths in 2024 to 2.48 thousand by 2028. This demonstrates a consistent upward trend over the five-year forecast period. Notably, this trend reflects a compound annual growth rate (CAGR) of approximately 0.94% from 2024 to 2028. As the data for 2023 is not specified, this analysis presumes stability or a baseline in mortality rates before entering the forecast period, allowing us to focus on the gradual rise observed in these years.
Future trends to watch include advancements in medical treatments and early detection technologies, which may impact mortality rates favorably. Additionally, changes in healthcare policy, public health initiatives, and lifestyle factors could significantly influence future mortality trends related to bladder malignant neoplasms in Canada.
